DXR Stock: Daxor Corporation Stock Price, Analysis & Insights
Get live DXR stock price $10.01, comprehensive Daxor Corporation stock analysis, charts, news, and expert forecast. Real-time DXR stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Based in Oak Ridge, Tennessee, Daxor Corporation is a medical technology enterprise founded in 1971. The company specializes in blood volume measurement, developing and commercializing the BVA-100 Blood Volume Analyzer. This diagnostic instrument off...
Company Information
- CEO
- Michael Richard Feldschuh
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 37
Contact Information
- Website
- https://www.daxor.com
- Address
- 109 Meco Lane
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 6.1)
✓ Lower volatility stock (Beta: 0.26) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Daxor Corporation shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Daxor Corporation
- ⚠Investors should consider how Daxor Corporation fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
50.44M
P/E Ratio (TTM)
6.10
Beta
0.26
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare DXR with peer companies:
- Price
- $7.39+0.82% (1D)
- Market cap
- 69.05M
- Price
- $3.69+10.99% (1D)
- Market cap
- 138.74M
- Price
- $0.76-0.98% (1D)
- Market cap
- 26.04M
- Price
- $2.43+10.22% (1D)
- Market cap
- 22.50M
- Price
- $1.68+2.13% (1D)
- Market cap
- 71.66M
- Price
- $2.21-0.45% (1D)
- Market cap
- 69.14M
- Price
- $0.72-3.96% (1D)
- Market cap
- 24.33M
- Price
- $3.22+0.63% (1D)
- Market cap
- 34.96M
- Price
- $3.84+1.99% (1D)
- Market cap
- 66.29M
- Price
- $2.36+0.43% (1D)
- Market cap
- 71.95M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
67/100 ⭐⭐⭐⭐
- Overall
- +0.3%
- NYSE
- +0.2%
- NASDAQ
- +0.4%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Energy | -0.4% | -6.3% | +1.4% | 37.1 | 75/100⭐⭐⭐⭐⭐ |
| Technology | +1.2% | -5.8% | +2.0% | 50.3 | 73/100⭐⭐⭐⭐⭐ |
| Financial Services | -0.5% | +0.9% | +0.9% | 19.3 | 72/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.3% | -2.1% | +1.2% | 30.4 | 67/100⭐⭐⭐⭐ |
| Industrials | +0.7% | -4.3% | +1.4% | 42.1 | 65/100⭐⭐⭐⭐ |
| Communication Services | -0.9% | -2.5% | +0.5% | 21.6 | 62/100⭐⭐⭐⭐ |
| Basic Materials | +0.4% | -3.7% | -1.2% | 27.0 | 49/100⭐⭐⭐ |
| Utilities | +1.2% | -3.8% | -5.4% | 25.7 | 24/100⭐ |
| Consumer Defensive | -0.1% | +2.2% | -2.3% | 31.2 | 22/100⭐ |
| Consumer Cyclical | +0.3% | -2.8% | -1.7% | 53.1 | 21/100⭐ |
| Real Estate | -1.1% | -2.0% | -2.0% | 50.0 | 20/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score: 70% 1M momentum percentile + 30% valuation percentile (lower P/E ranks higher), shown as 0–100 with stars. Data as of 2026-06-11.